Related Experiment Video

Updated: Aug 18, 2026

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
07:21

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD

A R Pons1, A Noguera, D Blanquer

  • 1Serveis de Analisis Clinics, Pneumologia, Hospital Universitari Son Dureta, Institut Universitari de Investigacións en Ciències de la Salut (IUNICS), Palma de Mallorca, Spain.

The European Respiratory Journal
|April 2, 2005
PubMed

Insights

Alveolar macrophages (AM) in chronic obstructive pulmonary disease (COPD) patients show reduced immune function. This local change in AM phenotype, specifically lower HLA-DR and CD80 expression, suggests impaired cell-mediated immunity in COPD.

Area of Science:

  • Immunology
  • Pulmonology
  • Cell Biology

Background:

  • Alveolar macrophages (AM) are key players in the inflammatory processes of chronic obstructive pulmonary disease (COPD).
  • Understanding changes in AM phenotypes is crucial for elucidating COPD pathogenesis.

Purpose of the Study:

  • To investigate alterations in the surface receptor expression of alveolar macrophages (AM) in patients with chronic obstructive pulmonary disease (COPD).
  • To compare AM phenotypes between COPD patients, healthy smokers, and non-smokers.

Main Methods:

  • Flow cytometry was used to assess the surface expression of various receptors on AM.
  • Receptors evaluated included those for phagocytosis (CD44, CD36, CD51, CD61, CD14), antigen presentation (HLA-DR), costimulation (CD80, CD86, CD40), and complement receptor type 3.
  • AM and peripheral blood monocytes from 18 COPD patients, 14 smokers, and 9 non-smokers were analyzed.

Main Results:

  • AM from COPD patients exhibited significantly lower surface expression of human leukocyte antigen (HLA)-DR and CD80 compared to smokers and non-smokers.
  • A higher percentage of COPD patients had AM with low surface expression of CD44.
  • No significant differences were observed in other studied receptors on AM or in peripheral blood monocytes between the groups.

Conclusions:

  • The cell-mediated immune function of alveolar macrophages appears to be reduced in patients with chronic obstructive pulmonary disease (COPD).
  • These observed changes in AM phenotype are likely a local phenomenon within the lung, rather than a systemic alteration.

More Related Videos

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages09:09

Isolation and In Vitro Culture of Murine and Human Alveolar Macrophages

Published on: April 20, 2018

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis07:47

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis

Published on: June 26, 2016

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History